Asterion Cannabis Officially Listed on the Australian Department of Health and Office of Drug Control
pharmaceutical investing PreveCeutical Announces LOI with Crushedit LLC to Supply CBD Isolate for Expected Sale Proceeds of $16.25 Million
pharmaceutical investing PreveCeutical Provides Update on Visit to Penta 5 Group’s Facility for Due Diligence on Proposed Acquisition
pharmaceutical investing PreveCeutical Holds Intensive Workshop to Advance Dual Gene Therapy Research Program for Type 2 Diabetes and Obesity
PreveCeutical Enters into Development Agreement with Asterion Cannabis Inc. to Develop Medicinal Cannabinoid Products
Asterion Enters Consulting Agreement with White Sheep Services Corp. and Appoints Hamish Sutherland as COO
West High Yield Resources Ltd. Announces Court Dismisses Judicial Review Challenging Record Ridge Project
SAGA Metals Reports Assays from R-0044 to R-0046 with Intercepts Including 58.33% Fe2O3, 8.78% TiO2, 0.415% V2O5 from 2026 Drilling at Trapper South, Radar Critical Minerals Project in Labrador